Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

HIPPUTOPE

IODOHIPPURATE SODIUM I-131

Standard Dose
1-2mCi/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview HIPPUTOPE is listed in Drugs@FDA under application 015419 (NDA).

Marketing status: Discontinued Active ingredient IODOHIPPURATE SODIUM I-131 Form and strength INJECTABLE;INJECTION - 1-2mCi/VIAL Sponsor BRACCO Submission history Latest submission status date: 2009-03-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview HIPPUTOPE is listed in Drugs@FDA under application 015419 (NDA). Marketing status: Discontinued Active ingredient IODOHIPPURATE SODIUM I-131 Form and strength INJECTABLE;INJECTION - 1-2mCi/VIAL Sponsor BRACCO Submission history Latest submission status date: 2009-03-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
HIPPUTOPE (IODOHIPPURATE SODIUM I-131) | Drug Monograph | MedicHelpline